EARLY PDD CYSTOSCOPY AFTER BCG INDUCTION INCREASES DETECTION OF BCG-REFRACTORY TUMORS

被引：0
|
作者：
Morelli, Michele [1 ]
Baboudjian, Michael [1 ]
Tadrist, Abel [1 ]
Gondran-tellier, Bastien [1 ]
Karsenty, Gilles [1 ]
Lechevallier, Eric [1 ]
Montanari, Emanuele [2 ]
Boissier, Romain [1 ]
机构：
[1] Conception Hosp, AP HM, Dept Urol & Kidney Transplantat, Marseilles, France
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Urol, Milan, Italy
来源：
ANTICANCER RESEARCH | 2021年 / 41卷 / 10期
关键词：
D O I：
10.21873/anticanres.15345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1
引用
下载
收藏
页码：5259 / 5259
页数：1
相关论文
共 50 条
  • [1] Early PDD cystoscopy after BCG induction for high-risk non-muscle invasive bladder cancer significantly increased the detection of BCG-refractory tumors
    Morelli, M.
    Baboudjian, M.
    Boissier, R.
    Vanacore, D.
    Karsenty, G.
    Montanari, E.
    Lechevallier, E.
    EUROPEAN UROLOGY, 2021, 79 : S984 - S985
  • [2] Early Photodynamic Diagnosis Cystoscopy After Bacillus Calmette-Guerin (BCG) Induction for High-Risk Nonmuscle Invasive Bladder Cancer Significantly Increased the Detection of BCG Refractory Tumors
    Morelli, Michele
    Baboudjian, Michael
    Vanacore, Davide
    Gondran-Tellier, Bastien
    McManus, Robin
    Karsenty, Gilles
    Lechevallier, Eric
    Montanari, Emanuele
    Boissier, Romain
    JOURNAL OF ENDOUROLOGY, 2021, 35 (12) : 1824 - 1828
  • [3] MANAGEMENT OF BCG-REFRACTORY SUPERFICIAL BLADDER CANCER
    Soyupak, Bulent
    TURKISH JOURNAL OF UROLOGY, 2005, 31 (04): : 465 - 468
  • [4] Valstar - For therapy of BCG-refractory urinary bladder carcinoma
    不详
    FORMULARY, 1998, 33 (11) : 1048 - 1048
  • [5] Is Intravesical Gene Therapy for Patients with BCG-refractory NMIBC?
    Bohle, A.
    UROLOGE, 2021, 60 (03): : 372 - 373
  • [6] USEFULNESS OF HEXVIX FLUORESCENCE CYSTOSCOPY AFTER BCG INDUCTION TREATMENT
    Pfister, C.
    Descotes, J. L.
    Conort, P.
    De La Taille, A.
    Colombel, M.
    Jacqmin, D.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 92 - 92
  • [7] Endovesical treatment with gemcitabine in patients with BCG-refractory superficial bladder carcinoma
    Gunelli, R.
    Frassineti, G. L.
    Giovannini, N.
    Zoli, W.
    Fiori, M.
    Amadori, D.
    Fabbri, P.
    Bercovich, E.
    ANNALS OF ONCOLOGY, 2006, 17 : XI78 - XI78
  • [8] ENDOVESICAL TREATMENT WITH GEMCITABINE IN PATIENTS WITH BCG-REFRACTORY SUPERFICIAL BLADDER CARCINOMA
    Gunelli, Roberta
    Frassineti, Giovanni Luca
    Giovannini, Noemi
    Zoli, Wainer
    Fiori, Massimo
    Saltutti, Carlo
    Amadori, Dino
    Bercovich, Eduard
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 96
  • [9] Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study
    Gunelli, R.
    Bercovich, E.
    Nanni, O.
    Ballardini, M.
    Frassineti, G. L.
    Giovannini, N.
    Fiori, M.
    Pasquini, E.
    Ulivi, P.
    Pappagallo, G. L.
    Silvestrini, R.
    Zoli, W.
    BRITISH JOURNAL OF CANCER, 2007, 97 (11) : 1499 - 1504
  • [10] Gemcitabine as an endovesical treatment in patients with BCG-refractory superficial bladder carcinoma.
    Gunelli, R
    Frassineti, GL
    Giovannini, N
    Zoli, W
    Fiori, M
    Amadori, D
    Fabbri, R
    Bercovich, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 429S - 429S
12345